Cite
HARVARD Citation
Schetelig, J. et al. (2019). Anti‐CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial. British journal of haematology. pp. 833-836. [Online].